3Spine

Name

3Spine

Legal name

3Spine, Inc.

Website

https://3spine.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

3Spine is a privately-held medical device company developing MOTUS, the first lumbar total joint replacement, as a motion-preserving alternative to spinal fusion for degenerative spine patients in the United States.

Ownership category

akta.pro rank

Product category

Spinal Implants and Motion Preservation Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)

akta.pro secondary industries

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA), Prosthetic Components & Rehabilitation Accessories (Liners, Feet, Knees, Sockets) (HLAHAMAD)

Keywords

• Lumbar total joint replacement
• Spinal motion preservation
• MOTUS spinal implant
• Spinal fusion alternative
• Lumbar degenerative surgery

Headquarters

HQ city

Chattanooga

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Medical Device Commercial Sales: 3Spine is currently pre-revenue as the MOTUS device is approved for investigational use only under FDA IDE. Upon FDA Pre-Market Approval (PMA), the company plans to commercially distribute the device through specialized Motion Surgery centers. Revenue will be generated through device sales and associated surgical procedures.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

3Spine develops, manufactures, and plans to commercially distribute the MOTUS lumbar total joint replacement, a motion-preserving spinal implant that replaces the function of both the disc and facet joints as a single prosthesis. Delivered via the BALANCEDBACK posterior surgical procedure, the device reestablishes stability after discectomy and broad decompression while preserving the anterior longitudinal ligament and enabling dynamic adaptation between standing and sitting postures. The product is currently investigational under FDA IDE and will be sold to hospitals and specialized Motion Surgery centers upon FDA Pre-Market Approval.

Product overview

3Spine is a medical device company offering a single unified product: the MOTUS™ Spinal Implant, which is the first total joint replacement for the lumbar spine. The MOTUS device replaces the function of the disc and facet joints as a total joint replacement (TJR) for the lumbar spine, offering a motion-preserving alternative to spinal fusion. The company also provides the associated BALANCEDBACK® surgical procedure for implant placement. The technology is currently in FDA Investigational Device Exemption (IDE) clinical trials and is not yet commercially available in the United States.

Differentiator

Problem solved

Functional benefit

Brands

• MOTUS: First total joint replacement device for the lumbar spine, replacing the function of the disc and facet joints.

Products and services

• MOTUS Spinal Implant The first total joint replacement for the lumbar spine, replacing the function of both the disc and facet joints as a single motion-preserving prosthesis for adult patients undergoing single-level lumbar reconstruction (L1/L2 to L5/S1) as an alternative to spinal fusion. Made of vitamin E stabilized polyethylene with cobalt chromium spherical counterfaces, intended for hospitals, surgeons, and patients with degenerative lumbar conditions.
• BALANCEDBACK Procedure A posterior-approach surgical procedure associated with the MOTUS device, in which the surgeon removes both facet joints, performs decompression and discectomy, and inserts the MOTUS prosthesis to reconstruct the functional spinal unit. Designed for spinal surgeons and hospitals treating single-level lumbar degenerative disease at L1/L2 through L5/S1.

Quantifiable outcome

• 2.4x improvement in Oswestry Disability Index (ODI) Substantial Clinical Benefit (SCB) compared to fusion at one year
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• FDAcoreStrategic or Co-development Partner · 1 January 20203Spine received Breakthrough Device Designation from FDA in 2020 and maintains close collaboration with both FDA and CMS. The company enjoys regulatory support for its IDE clinical trial and PMA pathway for the MOTUS lumbar total joint replacement.
• CMS (Centers for Medicare & Medicaid Services)coreStrategic or Co-development Partner · 1 January 20203Spine maintains close collaboration with CMS in addition to FDA, indicating alignment on coverage and reimbursement pathways for the MOTUS lumbar total joint replacement upon commercial approval.
• International Surgical (SEZC)minorOthers · 1 January 2016International Surgical purchased the IP in 2016, rebranding the technology as BalancedBack and then MOTUS. International Surgical SEZC became 3Spine SEZC then 3Spine, Inc. The company is now fully capitalized and entirely independent.
• MedtronicminorOthers · 1 January 20143Spine originated as a Medtronic spin-out. Medtronic purchased three-column IP in 2004 as the foundation for a posterior TJR IP portfolio, subsequently developing the KENAI device. In 2014, the portfolio was spun out to a private shell with Medtronic's support to complete additional refinements and the US IDE, leveraging private capital. The company is now fully independent.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Centinel Spine: Centinel Spine manufactures ProDisc L, one of two approved lumbar total disc replacement devices in the US. It is the most direct motion-preservation competitor to 3Spine's MOTUS, addressing a similar degenerative lumbar patient population with a different biomechanical approach.
• Highridge Medical: Highridge Medical offers the activL lumbar artificial disc, the second FDA-approved lumbar TDR in the US. It competes with 3Spine in motion-preserving treatment of single-level lumbar degenerative disc disease.
• Premia Spine: Premia Spine's TOPS System is a posterior motion-preservation implant designed to replace the function of the facet joints. It overlaps with 3Spine in addressing lumbar motion preservation as an alternative to fusion.

Broad incumbents

• Medtronic: Medtronic is a global spine incumbent and the originator of the three-column IP that became 3Spine's MOTUS. It sells a broad spine portfolio (including competitive fusion and interbody devices) and remains the dominant player in the US spinal implant market.
• NuVasive (Globus Medical): Globus Medical (which acquired NuVasive in 2023) is a broad spine incumbent with deep fusion, interbody, and emerging motion-preservation offerings. It competes in the same lumbar degenerative disease surgical setting as 3Spine.
• Stryker: Stryker's Spine division offers a comprehensive portfolio of cervical and lumbar fusion, interbody, and enabling technology products. It addresses the same lumbar degenerative patient population as 3Spine via the incumbent standard of care.

Emerging players

• Orthofix Medical: Orthofix is a smaller spine and orthopedics company with motion-preservation and biologics offerings. It is a more emerging competitor in the broader lumbar surgery market that 3Spine is targeting.
• ATEC (Alphatec Holdings): ATEC is a growth-stage spine company focused on degenerative and deformity surgery with a broad procedural portfolio. It is comparable in stage to 3Spine as a challenger to the major spine incumbents.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds6 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 3Spine